Attenuation correction in MR-PET scanners with segmented T1-weighted MR images

Attenuation correction of PET data acquired in new hybrid MR-PET scanners which do not offer the possibility of a measured attenuation correction can be done in different ways. A previous report of our group described a method which used attenuation templates. The present study utilizes a new knowledge-based segmentation approach applied on T1-weighted MR images. It examines the position and the tissue membership of each voxel and segments the head volume into attenuation-differing regions: brain tissue, extracerebral soft tissue, skull, air-filled nasal and paranasal cavities as well as the mastoid process. To examine this new approach three groups of subjects having MRI and PET were chosen, the selection criterion being the different MR scanners, while the PET scanner was the ECAT HR+ in all cases: 1) four subjects with 1.5T MR images and CPFPX PET scans, 2) four subjects with 3T MR images and Altanserin PET scans, and 3) three brain tumor patients with 3T MR images from the hybrid MR-BrainPET scanner and FET PET scans. Furthermore, a single subject had 3T MR images, a FDG PET scan, and an additional CT scan. All segmented T1-weighted MR images were converted into attenuation maps for 511 KeV photons with coefficients of 0.096 1/cm for brain tissue, 0.146 1/cm for skull, 0.095 1/cm for soft tissue, 0.054 1/cm for the mastoid process, and 0.0 1/cm for nasal and paranasal cavities. The CT volume was also converted from the Hounsfield units into attenuation coefficients valid for 511 keV photons. The 12 segmented-based attenuation (SBA) maps as well as the CT-based attenuation (CBA) map were first filtered by a 3D Gaussian kernel of 10 mm filter width and then used to reconstruct the corresponding PET emission data. These were compared to the PET images attenuation corrected using the conventional PET-based transmission data (PBA). Relative differences (RD) were calculated from ROIs. For the single subject the RD of CBA data exhibit a mean of 1.66%?0.84% with a range from -0.88% to 3.42%, while the RD's mean of SBA data is 1.42%?2.61% (range from -4.12% to 4.66%). Comparing the results obtained with the SBA correction only, the RD for 1) range from -6.10% to 2.56% for cortical regions and from -6.99% to 5.64% for subcortical regions; for 2) they range from -7.33% to 2.33% for the cortical regions, subcortical ones being not drawn due to the not significant tracer uptake; for 3) the mean over the three subjects resulted in 0.89%?1.10% for ROIs at 48% threshold of the image's maximum and in 2.25%?1.50% for ROIs at 72% threshold. ROIs on the healthy contra-lateral grey matter show a mean of -3.24%?0.87%. In conclusion, the first attenuation correction results obtained with the new segmented-based method on a strongly heterogeneous collective are very promising. Further improvements of the method will be focused on the delineation of the skull.

[1]  Hans Herzog,et al.  MRI Based Attenuation Correction for Brain PET Images , 2007 .

[2]  Karl Zilles,et al.  In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography , 2003, NeuroImage.

[3]  A. Buck,et al.  PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Gudrun Wagenknecht,et al.  Knowledge-based segmentation of attenuation-relevant regions of the head in T1-weighted MR images for attenuation correction in MR/PET systems , 2009, 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC).

[5]  Bernhard Schölkopf,et al.  MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.

[6]  Karl-Josef Langen,et al.  O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. , 2006, Nuclear medicine and biology.

[7]  P. Maquet,et al.  Serotonin 5HT2 Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [18F]Altanserin: Results in Young Normal Controls , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  G Wagenknecht,et al.  MRI-based individual 3D region-of-interest atlases of the human brain: a new method for analyzing functional data. , 2004, Methods of information in medicine.

[9]  Hans Herzog,et al.  Template based attenuation correction for PET in MR-PET scanners , 2008, 2008 IEEE Nuclear Science Symposium Conference Record.